MedTrace Logo

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

NCT01556828 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2016-06-24

No results posted yet for this study

Summary

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Conditions

  • Cutaneous Lymphoma
  • Other Skin Disorders
  • Mycosis Fungoides
  • Cutaneous T-cell Lymphoma

Sponsors & Collaborators

Principal Investigators

  • Paul Khavari, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01556828 on ClinicalTrials.gov